No defined primary molecular target

The designation "No defined primary molecular target" refers to a category of therapeutic agents that do not interact with a specific, identifiable protein or nucleic acid to produce their clinical effect (ChEMBL Database, 2024). Instead, these substances often work through physical or chemical processes, such as altering pH, changing osmotic pressure, or providing physical barriers (StatPearls, "Pharmacodynamics", 2023). Common examples include antacids like magnesium hydroxide, which chemically neutralize stomach acid, and osmotic diuretics like mannitol, which create an osmotic gradient in the renal tubules (PubChem, 2024). This classification is also used for drugs whose exact molecular mechanism remains elusive despite established clinical efficacy, or for diagnostic agents like contrast media that do not have a therapeutic biological target (DrugBank Online, 2024). Because these agents lack a specific molecular site of action, their pharmacological profiles are often characterized by broad physiological impacts rather than targeted molecular modulation. Understanding this category is crucial for drug developers and clinicians when evaluating agents that fall outside the traditional "lock-and-key" model of pharmacology. Consequently, the safety and efficacy of these compounds are typically monitored through systemic physiological changes rather than specific molecular biomarkers.

Other names

Unknown targetNon-specific mechanismTarget unknownUndefined targetNon-molecular mechanism

Non-specific physical or chemical interactions, such as acid neutralization, osmotic fluid shifting, physical adsorption, or altering surface tension.